share_log

Clever Leaves and Astrasana Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and Switzerland

Clever Leaves and Astrasana Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and Switzerland

Clever Leaves和Astrasana合作在捷克共和國和瑞士建立醫用大麻提取物國際供應協議
GlobeNewswire ·  2023/05/30 20:30

TOCANCIPÁ, Colombia, May 30, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) ("Clever Leaves"), a global medicinal cannabis company, announced today the arrival of the company's first shipment of medical cannabis extracts from Colombia to Switzerland-based partner, Astrasana Holding AG ("Astrasana"). This marks the first commercial shipment for Clever Leaves to Switzerland, where Astrasana is an established medical cannabis distributor.

哥倫比亞託坎西帕2023年5月30日(GLOBE NEWSWIRE)——全球藥用大麻公司Clever Leaves Holdings Inc.(納斯達克股票代碼:CLVR,CLVRW)(“Clever Leaves”)今天宣佈,該公司的第一批醫用大麻提取物從哥倫比亞運抵瑞士的合作伙伴Astrasana Holdings AG(“Astrasana”)。這標誌着 Clever Leaves 首次向瑞士商業發貨,Astrasana 是瑞士的老牌醫用大麻分銷商。

Additionally, Clever Leaves and Astrasana are preparing for the first shipment of medical cannabis extracts to the Czech Republic, where Astrasana has pharmaceutical operations and manages its own pharmacy specialising in the sale of medical cannabis.

此外,Clever Leaves和Astrasana正在準備向捷克共和國運送第一批醫用大麻提取物,Astrasana在那裏開展製藥業務,並管理自己的專門銷售醫用大麻的藥房。

The supply agreement between Clever Leaves and Astrasana will allow Clever Leaves to expand into new European markets and further solidify its position as a global provider of medical cannabis. Switzerland and the Czech Republic have both seen recent legislative changes in favor of medical cannabis and are at the forefront of the emerging European cannabis industry.

Clever Leaves和Astrasana之間的供應協議將使Clever Leaves能夠擴展到新的歐洲市場,並進一步鞏固其作爲全球醫用大麻供應商的地位。瑞士和捷克共和國最近都發生了有利於醫用大麻的立法變化,並且處於歐洲新興大麻產業的最前沿。

"The Supply Agreement guarantees Astrasana a reliable and consistent supply of medical cannabis extracts at competitive prices, providing planning certainty and allowing for seamless operations," says CEO of Astrasana Holding, Yves Antoniazzi. "This partnership with Clever Leaves not only ensures a steady supply of premium medical cannabis products for Astrasana's customers, but also intensifies the existing collaboration between the two companies, paving the way for future growth opportunities."

Astrasana Holding首席執行官Yves Antoniazzi表示:“供應協議保證了Astrasana以具有競爭力的價格可靠和持續地供應醫用大麻提取物,從而提供了規劃的確定性並允許無縫運營。”“與Clever Leaves的合作不僅確保了爲Astrasana的客戶穩定供應優質醫用大麻產品,而且加強了兩家公司之間的現有合作,爲未來的增長機會鋪平了道路。”

Clever Leaves, a publicly traded company with a well-regarded reputation in the cannabis industry, has been operating since 2016 and is known for its expertise in producing high-quality medical cannabis extracts. The company's commitment to upholding the highest standards in the industry aligns perfectly with Astrasana's values and mission to provide safe and effective medical cannabis products to patients worldwide.

Clever Leaves是一家在大麻行業享有良好聲譽的上市公司,自2016年開始運營,以其生產高質量醫用大麻提取物的專業知識而聞名。該公司對維護行業最高標準的承諾完全符合Astrasana的價值觀和使命,即爲全球患者提供安全有效的醫用大麻產品。

"Clever Leaves' first commercial shipment of medical cannabis extracts to Astrasana in Switzerland marks a significant step towards our goal of expanding patient access to high-quality medical cannabis across Europe and beyond. Through our strategic partnership with Astrasana, we look forward to aligning our capabilities and further penetrating new countries in Europe such as Switzerland and Czech Republic. As a company, we remain focused on driving innovation in the industry and creating safe, pharmaceutical-grade products for patients in need," said Co-Founder and CEO of Clever Leaves, Andres Fajardo.
With Clever Leaves' global reach and expertise in the cannabis industry, Astrasana is poised to further strengthen its position as a leading provider and distributor of medical cannabis in the Czech Republic and Switzerland.

“Clever Leaves首次向瑞士的Astrasana商業運送醫用大麻提取物,這標誌着我們朝着擴大歐洲及其他地區患者獲得高質量醫用大麻的機會的目標邁出了重要一步。通過與Astrasana的戰略伙伴關係,我們期待調整我們的能力,進一步滲透瑞士和捷克共和國等歐洲新國家。作爲一家公司,我們仍然專注於推動行業創新,爲有需要的患者創造安全的藥品級產品。” Clever Leaves聯合創始人兼首席執行官安德烈斯·法哈多說。
憑藉Clever Leaves在大麻行業的全球影響力和專業知識,Astrasana有望進一步鞏固其作爲捷克共和國和瑞士領先醫用大麻提供商和分銷商的地位。

About Astrasana
Astrasana is a pioneering company in the field of medical cannabis, with manufacturing and retail locations in the Czech Republic and Switzerland. With comprehensive pharmaceutical licenses and a strong focus on quality, sustainability, innovation, and customer satisfaction, Astrasana is dedicated to providing safe and effective medical cannabis products to patients. Astrasana's board of directors consists of doctors and pharmacists which allow the company to have a competitive advantage.

關於 Astrasana
Astrasana是醫用大麻領域的開創性公司,在捷克共和國和瑞士設有製造和零售地點。憑藉全面的藥品許可證以及對質量、可持續性、創新和客戶滿意度的高度關注,Astrasana致力於爲患者提供安全有效的醫用大麻產品。Astrasana的董事會由醫生和藥劑師組成,這使公司具有競爭優勢。

About Clever Leaves Holdings Inc.
Clever Leaves is a global medical cannabis company. Its operations in Colombia produce EU GMP cannabinoid active pharmaceutical ingredients (API) and finished products in flower and extract form to a growing base of B2B customers around the globe. Clever Leaves aims to disrupt the traditional cannabis production industry by leveraging environmentally sustainable, ESG-friendly, industrial-scale and low-cost production methods, with the world's most stringent pharmaceutical quality certifications. For more information, please visit and follow Clever Leaves on Twitter and LinkedIn.

關於 Clever Leaves 控股公司
Clever Leaves 是一家全球醫用大麻公司。其在哥倫比亞的業務爲全球越來越多的B2B客戶生產歐盟GMP大麻素活性藥物成分(API)和花卉和提取物形式的成品。Clever Leaves旨在通過利用環境可持續、ESG友好、工業規模和低成本的生產方法以及世界上最嚴格的藥品質量認證,來顛覆傳統的大麻生產行業。欲瞭解更多信息,請訪問並關注 Twitter 和 LinkedIn 上的 Clever Leaves。

Clever Leaves Press Contacts:
Maria Petsanas
KCSA Strategic Communications
+1-917-692-6673 | cleverleaves@kcsa.com

Clever Leaves 新聞聯繫人
瑪麗亞·佩薩納斯
KCSA 戰略傳播
+1-917-692-6673 | cleverleaves@kcsa.com

Clever Leaves Investor Inquiries:
Cody Slach and Jackie Keshner
Gateway Group, Inc.
+1-949-574-3860 | CLVR@gatewayir.com

Clever 離開了投資者的詢問:
Cody Slach 和 Jackie Keshner
蓋特威集團有限公司
+1-949-574-3860 | CLVR@gatewayir.com

Clever Leaves Commercial Contact:
Andrew Miller
Head of Global Business Development
andrew.miller@cleverleaves.com
+1 416-817-1336

Clever 留下商業聯繫方式:
安德魯·米勒
全球業務發展主管
andrew.miller@cleverleaves.com
+1 416-817-1336


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論